Search

everythinglearnresearchcommunity

for

Search:↓

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Platelet Rich Plasma (PRP) shows promise for tissue repair and immune response, but more research is needed to fully understand it and optimize its use.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Treating epilepsy is complex, requiring careful drug choice and patient adherence to manage seizures and side effects.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Many adult women suffer from persistent or late-onset acne, and while various treatments exist, finding the right one can be challenging.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Both mouse and rat models are effective for testing alopecia areata treatments.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

New hair follicle-targeting treatments show promise for hair disorders but need more research on safety and effectiveness.

The gel with CBD and EPA reduced wrinkles, improved skin hydration and elasticity, and had strong anti-aging effects.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Fractional laser therapy is a promising, effective, and minimally invasive treatment for hair loss.

Finasteride 5mg daily is the most effective for female pattern hair loss, with higher doses of treatments generally more effective.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

QR 678 and QR 678 Neo are safe and promote hair growth, potentially helping chemotherapy-induced hair loss.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Mesotherapy might improve hair growth, but more research is needed to confirm its safety and effectiveness.

More personalized and effective treatments for androgenetic alopecia are needed.